ChromoGenics AB
ABActiveOrg 5566301809Ullforsgatan 15, 752 28 UppsalaManufacture of doors and windows of metal· NACE 2512Est. 2002 · 24 years old25 employees
Loading company…
Overview
ChromoGenics AB is a Swedish AB based in Uppsala, operating in the Manufacture of doors and windows of metal sector. Incorporated in 2002, the company has 25 employees and reported revenue of SEK 23.4m in its latest annual filing.
Revenue 2026
23.4M SEK
+45% vs 2025
EBITDA margin
−137.6 %
−77% vs 2025
Net profit 2026
4.9M SEK
+116% vs 2025
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
41.1 %
AverageAround the average of companies in the same industry
20212026
Liquidity ratioCurrent assets ÷ Short-term debt
4.1×
StrongAmong the 30% highest rated companies in the industry
20212026
Return on assets (ROA)Net profit ÷ Total assets × 100
2.8 %
AverageAround the average of companies in the same industry
20212026
EBITDA — year on year
SEK millionsKey figures
Annual report 2026| Revenue | 23.4M SEK | +45% |
| EBITDA | -32.2M SEK | -77% |
| Net profit | 4.9M SEK | +116% |
| Total assets | 176.6M SEK | +47% |
| Equity | 72.7M SEK | +161% |
| Employees | 25 | — |
Company information
Legal name
ChromoGenics AB
Org number
5566301809
Legal form
Aktiebolag
NACE code
Founded
5 July 2002 · 24 years
Share capital
SEK 36,470,000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2026-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva utveckling, tillverkning och marknadsföring av foliebaserade produkter med elektrisk styrbar ljusgenomsläpplighet samt bedriva därmed förenlig verksamhet.
(no translation available)
Contact
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2026), ChromoGenics AB reported revenue of SEK 23.4m, an increase of 45% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2026. The bottom line showed a net profit of SEK 4.9m, and the EBITDA margin stood at -137.6%.
At the end of 2026, equity financed 41.1% of the balance sheet, and current assets covered short-term debt 4.1 times.
Financials
Revenue
SEK millionsEBITDA
SEK millionsIncome statement
SEK thousands| Item | 2026 | 2025 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 23,414 | 16,146 | 13,645 | 18,260 | 24,690 |
| Staff expenses | -24,892 | — | — | — | — |
| EBITDA | -32,211 | -18,157 | -44,271 | -52,555 | -57,369 |
| Depreciation & amort. | -5,116 | -7,109 | -4,475 | -3,370 | -2,286 |
| EBIT | -37,327 | -25,266 | -48,746 | -55,925 | -59,655 |
| Net financials | -2,811 | -5,837 | -3,763 | -1,050 | -3,878 |
| Profit before tax | 4,862 | -31,102 | -52,509 | -56,976 | -63,533 |
| Tax | -0 | -0 | 3 | -0 | -0 |
| Net profit | 4,862 | -31,102 | -52,506 | -56,976 | -63,533 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
SEK thousands| Item | 2026 | 2025 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 176,591 | 120,178 | 139,163 | 161,501 | 160,444 |
| Equity | 72,653 | 27,791 | 42,755 | 70,488 | 57,702 |
| Long-term debt | 75,861 | 74,552 | 69,046 | 66,159 | 50,103 |
| Short-term debt | 19,534 | 9,627 | 27,362 | 24,854 | 52,639 |
| Total debt | 95,395 | 84,179 | 96,408 | 91,013 | 102,742 |
Financial ratios
5-year trendEBITDA margin
-137.6 %
20212026
Equity ratio
41.1 %
AverageAround the average of companies in the same industry
20212026
Return on equity
6.7 %
AverageAround the average of companies in the same industry
20212026
Net profit margin
20.8 %
Very strongAmong the 20% highest rated companies in the industry
20212026
Asset turnover
0.13×
Very weakAmong the 20% lowest rated companies in the industry
20212026
Debt / equity
1.43×
WeakAmong the 40% lowest rated companies in the industry
20212026
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 10% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery strong
Among the 20% highest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery weak
Among the 10% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 30% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioStrong
Among the 30% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 40% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 30% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalWeak
Among the 40% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery weak
Among the 10% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioAverage
Around the average of companies in the same industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioWeak
Among the 40% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityWeak
Among the 40% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityWeak
Among the 40% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtVery weak
Among the 20% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginAverage
Around the average of companies in the same industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverVery weak
Among the 20% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverVery strong
Among the 20% highest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 40% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2026Filed via Bolagsverket / SCB · Period 2025-05-01 – 2026-04-30
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-01-01 – 2025-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
FC Chief Executive Officer | Chief Executive Officer | 2022 |
PI Chief Auditor | Chief Auditor | 2025 |
Former (3)
LA Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
JE Chief Auditor | Chief Auditor | 2020 – 2025 |
SJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JO Chairman | Chairman | 2020 |
AÅ Board of Directors | Board of Directors | 2025 |
JF Board of Directors | Board of Directors | 2020 |
Former (6)
EA Board of Directors | Board of Directors | 2022 – 2025 |
BP Board of Directors | Board of Directors | 2020 – 2021 |
PC Board of Directors | Board of Directors | 2020 – 2020 |
AH Board of Directors | Board of Directors | 2020 – 2025 |
SH Board of Directors | Board of Directors | 2020 – 2025 |
CS Board of Directors | Board of Directors | 2020 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Färna Invest AB
ChromoGenics AB Board network connections
Board members of ChromoGenics AB also hold positions in 342 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Erik Niclas Bergenmo | Chief Auditor | 160 companiesMany roles |
| Per Inge Andreas Pettersson | Chief Auditor | 149 companiesMany roles |
| Erik Anders Brännström | Board of Directors | 8 companiesMany roles |
| Johan Olov Hedin | Chairman | 6 companiesMany roles |
| Leif Arne Ljungqvist | Chief Executive Officer | 4 companies |
| Alva Åqvist | Board of Directors | 4 companies |
| Stig Jerker Lundgren | Chief Executive Officer | 3 companies |
| Sirpa Helena Engman | Board of Directors | 3 companies |
| Bertil Peter Gustafson | Board of Directors | 2 companies |
| Peter Carl Gustav Edelsvärd | Board of Directors | 2 companies |
| Fredrik Carl Fränding | Chief Executive Officer | 1 company |
Frequently asked questions
What is the Org number of ChromoGenics AB?
ChromoGenics AB is registered with Bolagsverket / SCB under Org 5566301809.
What is the revenue of ChromoGenics AB?
ChromoGenics AB reported revenue of SEK 23.4m in 2026.
How many employees does ChromoGenics AB have?
ChromoGenics AB employs 25 people as of the latest annual report.
Who is the CEO of ChromoGenics AB?
Fredrik Carl Fränding is the CEO of ChromoGenics AB, in role since 2022.
Who is the chairman of ChromoGenics AB?
Johan Olov Hedin chairs the board of ChromoGenics AB, in role since 2020.
Where is ChromoGenics AB headquartered?
ChromoGenics AB's registered address is Ullforsgatan 15.